# Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis

> **NCT01155765** · PHASE3 · COMPLETED · sponsor: **University of Patras** · enrollment: 70 (estimated)

## Conditions studied

- Hemodialysis
- Chronic Renal Failure

## Interventions

- **DRUG:** Prasugrel
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01155765
- **Lead sponsor:** University of Patras
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2010-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01155765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01155765, "Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01155765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*